nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.208	0.353	CbGbCtD
Repaglinide—CYP2C8—Progesterone—uterine cancer	0.138	0.234	CbGbCtD
Repaglinide—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0845	0.143	CbGbCtD
Repaglinide—CYP2C8—Etoposide—uterine cancer	0.0617	0.105	CbGbCtD
Repaglinide—CYP3A4—Progesterone—uterine cancer	0.056	0.0948	CbGbCtD
Repaglinide—CYP3A4—Etoposide—uterine cancer	0.025	0.0424	CbGbCtD
Repaglinide—CYP3A4—Doxorubicin—uterine cancer	0.0171	0.0289	CbGbCtD
Repaglinide—PPARG—Teniposide—Etoposide—uterine cancer	0.00628	1	CbGdCrCtD
Repaglinide—PPARG—artery—uterine cancer	0.00551	0.119	CbGeAlD
Repaglinide—ABCC8—smooth muscle tissue—uterine cancer	0.00264	0.0568	CbGeAlD
Repaglinide—Hepatic function abnormal—Medroxyprogesterone Acetate—uterine cancer	0.0026	0.0115	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Progesterone—uterine cancer	0.00259	0.0115	CcSEcCtD
Repaglinide—ABCC8—renal system—uterine cancer	0.00254	0.0547	CbGeAlD
Repaglinide—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00252	0.0112	CcSEcCtD
Repaglinide—Cardiac failure congestive—Medroxyprogesterone Acetate—uterine cancer	0.00251	0.0111	CcSEcCtD
Repaglinide—ABCC8—endometrium—uterine cancer	0.00246	0.0529	CbGeAlD
Repaglinide—Visual disturbance—Medroxyprogesterone Acetate—uterine cancer	0.0024	0.0106	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.00235	0.0104	CcSEcCtD
Repaglinide—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00233	0.0103	CcSEcCtD
Repaglinide—SLCO1B1—renal system—uterine cancer	0.00225	0.0484	CbGeAlD
Repaglinide—KCNJ11—female reproductive system—uterine cancer	0.00221	0.0476	CbGeAlD
Repaglinide—Angina pectoris—Progesterone—uterine cancer	0.00211	0.00936	CcSEcCtD
Repaglinide—PPARG—epithelium—uterine cancer	0.00209	0.045	CbGeAlD
Repaglinide—Bronchitis—Progesterone—uterine cancer	0.00208	0.00924	CcSEcCtD
Repaglinide—PPARG—smooth muscle tissue—uterine cancer	0.00201	0.0434	CbGeAlD
Repaglinide—Cardiovascular disorder—Etoposide—uterine cancer	0.00201	0.00892	CcSEcCtD
Repaglinide—KCNJ11—female gonad—uterine cancer	0.00201	0.0433	CbGeAlD
Repaglinide—PPARG—decidua—uterine cancer	0.00197	0.0425	CbGeAlD
Repaglinide—Hyperglycaemia—Progesterone—uterine cancer	0.00195	0.00867	CcSEcCtD
Repaglinide—PPARG—renal system—uterine cancer	0.00194	0.0418	CbGeAlD
Repaglinide—Bronchitis—Medroxyprogesterone Acetate—uterine cancer	0.00189	0.00837	CcSEcCtD
Repaglinide—Jaundice—Progesterone—uterine cancer	0.00188	0.00835	CcSEcCtD
Repaglinide—Urinary tract infection—Progesterone—uterine cancer	0.00188	0.00833	CcSEcCtD
Repaglinide—Hepatobiliary disease—Progesterone—uterine cancer	0.00183	0.0081	CcSEcCtD
Repaglinide—PPARG—mammalian vulva—uterine cancer	0.00181	0.0391	CbGeAlD
Repaglinide—Sinusitis—Progesterone—uterine cancer	0.00181	0.00804	CcSEcCtD
Repaglinide—SLCO1B1—female reproductive system—uterine cancer	0.0018	0.0388	CbGeAlD
Repaglinide—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00177	0.00785	CcSEcCtD
Repaglinide—Rhinitis—Progesterone—uterine cancer	0.00174	0.00771	CcSEcCtD
Repaglinide—Hepatitis—Progesterone—uterine cancer	0.00173	0.00769	CcSEcCtD
Repaglinide—PPARG—uterus—uterine cancer	0.00173	0.0372	CbGeAlD
Repaglinide—Acute coronary syndrome—Medroxyprogesterone Acetate—uterine cancer	0.00173	0.00765	CcSEcCtD
Repaglinide—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	0.00172	0.00761	CcSEcCtD
Repaglinide—Oedema peripheral—Progesterone—uterine cancer	0.00171	0.00758	CcSEcCtD
Repaglinide—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.00757	CcSEcCtD
Repaglinide—Urinary tract infection—Medroxyprogesterone Acetate—uterine cancer	0.0017	0.00755	CcSEcCtD
Repaglinide—Visual impairment—Progesterone—uterine cancer	0.00167	0.00741	CcSEcCtD
Repaglinide—Hepatobiliary disease—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.00734	CcSEcCtD
Repaglinide—Sinusitis—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.00728	CcSEcCtD
Repaglinide—Erythema multiforme—Progesterone—uterine cancer	0.00164	0.00727	CcSEcCtD
Repaglinide—Eye disorder—Progesterone—uterine cancer	0.00162	0.00719	CcSEcCtD
Repaglinide—Cardiac disorder—Progesterone—uterine cancer	0.00161	0.00714	CcSEcCtD
Repaglinide—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00157	0.00697	CcSEcCtD
Repaglinide—Immune system disorder—Progesterone—uterine cancer	0.00157	0.00695	CcSEcCtD
Repaglinide—PPARG—female reproductive system—uterine cancer	0.00155	0.0334	CbGeAlD
Repaglinide—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.00686	CcSEcCtD
Repaglinide—Alopecia—Progesterone—uterine cancer	0.00153	0.0068	CcSEcCtD
Repaglinide—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.00672	CcSEcCtD
Repaglinide—Malnutrition—Progesterone—uterine cancer	0.00151	0.00669	CcSEcCtD
Repaglinide—Erythema—Progesterone—uterine cancer	0.00151	0.00669	CcSEcCtD
Repaglinide—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00149	0.00659	CcSEcCtD
Repaglinide—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.00651	CcSEcCtD
Repaglinide—Back pain—Progesterone—uterine cancer	0.00146	0.00648	CcSEcCtD
Repaglinide—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00647	CcSEcCtD
Repaglinide—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00629	CcSEcCtD
Repaglinide—Cardiac failure congestive—Etoposide—uterine cancer	0.00141	0.00627	CcSEcCtD
Repaglinide—PPARG—female gonad—uterine cancer	0.00141	0.0304	CbGeAlD
Repaglinide—PPARG—vagina—uterine cancer	0.0014	0.0303	CbGeAlD
Repaglinide—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.00616	CcSEcCtD
Repaglinide—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.00607	CcSEcCtD
Repaglinide—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.00607	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.00135	0.006	CcSEcCtD
Repaglinide—Palpitations—Progesterone—uterine cancer	0.00133	0.00592	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Etoposide—uterine cancer	0.00133	0.00588	CcSEcCtD
Repaglinide—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00132	0.00587	CcSEcCtD
Repaglinide—Hypertension—Progesterone—uterine cancer	0.0013	0.00578	CcSEcCtD
Repaglinide—KCNJ11—lymph node—uterine cancer	0.00129	0.0278	CbGeAlD
Repaglinide—Chest pain—Progesterone—uterine cancer	0.00129	0.0057	CcSEcCtD
Repaglinide—Arthralgia—Progesterone—uterine cancer	0.00129	0.0057	CcSEcCtD
Repaglinide—CYP2C8—renal system—uterine cancer	0.00128	0.0275	CbGeAlD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00128	0.00566	CcSEcCtD
Repaglinide—CYP2C8—endometrium—uterine cancer	0.00124	0.0266	CbGeAlD
Repaglinide—Anaphylactic shock—Progesterone—uterine cancer	0.00123	0.00546	CcSEcCtD
Repaglinide—Oedema—Progesterone—uterine cancer	0.00123	0.00546	CcSEcCtD
Repaglinide—Hepatitis—Dactinomycin—uterine cancer	0.00123	0.00544	CcSEcCtD
Repaglinide—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00536	CcSEcCtD
Repaglinide—Skin disorder—Progesterone—uterine cancer	0.0012	0.00531	CcSEcCtD
Repaglinide—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00516	CcSEcCtD
Repaglinide—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00516	CcSEcCtD
Repaglinide—Erythema multiforme—Dactinomycin—uterine cancer	0.00116	0.00514	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00513	CcSEcCtD
Repaglinide—Cardiovascular disorder—Epirubicin—uterine cancer	0.00113	0.005	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00112	0.00498	CcSEcCtD
Repaglinide—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00495	CcSEcCtD
Repaglinide—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00495	CcSEcCtD
Repaglinide—Paraesthesia—Progesterone—uterine cancer	0.00111	0.00491	CcSEcCtD
Repaglinide—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00485	CcSEcCtD
Repaglinide—Dyspepsia—Progesterone—uterine cancer	0.00108	0.00481	CcSEcCtD
Repaglinide—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00481	CcSEcCtD
Repaglinide—Alopecia—Dactinomycin—uterine cancer	0.00108	0.0048	CcSEcCtD
Repaglinide—Erythema—Dactinomycin—uterine cancer	0.00107	0.00473	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Progesterone—uterine cancer	0.00106	0.00472	CcSEcCtD
Repaglinide—Constipation—Progesterone—uterine cancer	0.00105	0.00467	CcSEcCtD
Repaglinide—Cardiovascular disorder—Doxorubicin—uterine cancer	0.00104	0.00462	CcSEcCtD
Repaglinide—CYP2C8—female reproductive system—uterine cancer	0.00102	0.0221	CbGeAlD
Repaglinide—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00451	CcSEcCtD
Repaglinide—Gastrointestinal pain—Progesterone—uterine cancer	0.00101	0.00447	CcSEcCtD
Repaglinide—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.001	0.00445	CcSEcCtD
Repaglinide—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000983	0.00436	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00098	0.00434	CcSEcCtD
Repaglinide—Urticaria—Progesterone—uterine cancer	0.000979	0.00434	CcSEcCtD
Repaglinide—Acute coronary syndrome—Etoposide—uterine cancer	0.000974	0.00432	CcSEcCtD
Repaglinide—Abdominal pain—Progesterone—uterine cancer	0.000974	0.00432	CcSEcCtD
Repaglinide—Myocardial infarction—Etoposide—uterine cancer	0.000969	0.0043	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000964	0.00427	CcSEcCtD
Repaglinide—Jaundice—Etoposide—uterine cancer	0.000963	0.00427	CcSEcCtD
Repaglinide—Leukopenia—Dactinomycin—uterine cancer	0.000955	0.00424	CcSEcCtD
Repaglinide—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000955	0.00423	CcSEcCtD
Repaglinide—Hepatobiliary disease—Etoposide—uterine cancer	0.000935	0.00414	CcSEcCtD
Repaglinide—CYP2C8—vagina—uterine cancer	0.000926	0.0199	CbGeAlD
Repaglinide—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000913	0.00405	CcSEcCtD
Repaglinide—PPARG—lymph node—uterine cancer	0.000909	0.0196	CbGeAlD
Repaglinide—Hypersensitivity—Progesterone—uterine cancer	0.000908	0.00403	CcSEcCtD
Repaglinide—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000887	0.00393	CcSEcCtD
Repaglinide—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000883	0.00391	CcSEcCtD
Repaglinide—Pruritus—Progesterone—uterine cancer	0.000872	0.00387	CcSEcCtD
Repaglinide—Oedema—Dactinomycin—uterine cancer	0.000871	0.00386	CcSEcCtD
Repaglinide—CYP3A4—renal system—uterine cancer	0.000866	0.0187	CbGeAlD
Repaglinide—Thrombocytopenia—Dactinomycin—uterine cancer	0.000853	0.00378	CcSEcCtD
Repaglinide—ALB—lymph node—uterine cancer	0.000852	0.0184	CbGeAlD
Repaglinide—Diarrhoea—Progesterone—uterine cancer	0.000843	0.00374	CcSEcCtD
Repaglinide—Erythema multiforme—Etoposide—uterine cancer	0.000839	0.00372	CcSEcCtD
Repaglinide—Eye disorder—Etoposide—uterine cancer	0.000829	0.00368	CcSEcCtD
Repaglinide—Cardiac disorder—Etoposide—uterine cancer	0.000823	0.00365	CcSEcCtD
Repaglinide—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000823	0.00365	CcSEcCtD
Repaglinide—Hepatic function abnormal—Epirubicin—uterine cancer	0.000823	0.00365	CcSEcCtD
Repaglinide—Immune system disorder—Etoposide—uterine cancer	0.000801	0.00355	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000793	0.00352	CcSEcCtD
Repaglinide—Cardiac failure congestive—Epirubicin—uterine cancer	0.000793	0.00351	CcSEcCtD
Repaglinide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00079	0.0035	CcSEcCtD
Repaglinide—Alopecia—Etoposide—uterine cancer	0.000784	0.00348	CcSEcCtD
Repaglinide—Vomiting—Progesterone—uterine cancer	0.000783	0.00347	CcSEcCtD
Repaglinide—Rash—Progesterone—uterine cancer	0.000777	0.00344	CcSEcCtD
Repaglinide—Dermatitis—Progesterone—uterine cancer	0.000776	0.00344	CcSEcCtD
Repaglinide—Headache—Progesterone—uterine cancer	0.000772	0.00342	CcSEcCtD
Repaglinide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000764	0.00339	CcSEcCtD
Repaglinide—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000761	0.00337	CcSEcCtD
Repaglinide—Back pain—Etoposide—uterine cancer	0.000747	0.00331	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000743	0.00329	CcSEcCtD
Repaglinide—Hypoglycaemia—Epirubicin—uterine cancer	0.000737	0.00327	CcSEcCtD
Repaglinide—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000733	0.00325	CcSEcCtD
Repaglinide—Nausea—Progesterone—uterine cancer	0.000732	0.00325	CcSEcCtD
Repaglinide—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000712	0.00316	CcSEcCtD
Repaglinide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00071	0.00315	CcSEcCtD
Repaglinide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000704	0.00312	CcSEcCtD
Repaglinide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000703	0.00312	CcSEcCtD
Repaglinide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000699	0.0031	CcSEcCtD
Repaglinide—CYP3A4—female reproductive system—uterine cancer	0.000693	0.0149	CbGeAlD
Repaglinide—Leukopenia—Etoposide—uterine cancer	0.000691	0.00307	CcSEcCtD
Repaglinide—Abdominal pain—Dactinomycin—uterine cancer	0.000688	0.00305	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000687	0.00305	CcSEcCtD
Repaglinide—Hypoglycaemia—Doxorubicin—uterine cancer	0.000682	0.00302	CcSEcCtD
Repaglinide—Hypertension—Etoposide—uterine cancer	0.000667	0.00296	CcSEcCtD
Repaglinide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000663	0.00294	CcSEcCtD
Repaglinide—Chest pain—Etoposide—uterine cancer	0.000658	0.00292	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000653	0.0029	CcSEcCtD
Repaglinide—Hypersensitivity—Dactinomycin—uterine cancer	0.000642	0.00284	CcSEcCtD
Repaglinide—Anaphylactic shock—Etoposide—uterine cancer	0.00063	0.00279	CcSEcCtD
Repaglinide—Thrombocytopenia—Etoposide—uterine cancer	0.000617	0.00274	CcSEcCtD
Repaglinide—Skin disorder—Etoposide—uterine cancer	0.000612	0.00271	CcSEcCtD
Repaglinide—Pancreatitis—Epirubicin—uterine cancer	0.000609	0.0027	CcSEcCtD
Repaglinide—Angina pectoris—Epirubicin—uterine cancer	0.000605	0.00268	CcSEcCtD
Repaglinide—Bronchitis—Epirubicin—uterine cancer	0.000598	0.00265	CcSEcCtD
Repaglinide—Diarrhoea—Dactinomycin—uterine cancer	0.000596	0.00264	CcSEcCtD
Repaglinide—Paraesthesia—Etoposide—uterine cancer	0.000566	0.00251	CcSEcCtD
Repaglinide—Pancreatitis—Doxorubicin—uterine cancer	0.000564	0.0025	CcSEcCtD
Repaglinide—Hyperglycaemia—Epirubicin—uterine cancer	0.00056	0.00249	CcSEcCtD
Repaglinide—Angina pectoris—Doxorubicin—uterine cancer	0.00056	0.00248	CcSEcCtD
Repaglinide—Vomiting—Dactinomycin—uterine cancer	0.000554	0.00246	CcSEcCtD
Repaglinide—Bronchitis—Doxorubicin—uterine cancer	0.000553	0.00245	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000549	0.00244	CcSEcCtD
Repaglinide—Rash—Dactinomycin—uterine cancer	0.000549	0.00243	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Etoposide—uterine cancer	0.000544	0.00241	CcSEcCtD
Repaglinide—Jaundice—Epirubicin—uterine cancer	0.00054	0.00239	CcSEcCtD
Repaglinide—Constipation—Etoposide—uterine cancer	0.000539	0.00239	CcSEcCtD
Repaglinide—Urinary tract infection—Epirubicin—uterine cancer	0.000539	0.00239	CcSEcCtD
Repaglinide—Hepatobiliary disease—Epirubicin—uterine cancer	0.000524	0.00232	CcSEcCtD
Repaglinide—Sinusitis—Epirubicin—uterine cancer	0.00052	0.0023	CcSEcCtD
Repaglinide—Hyperglycaemia—Doxorubicin—uterine cancer	0.000519	0.0023	CcSEcCtD
Repaglinide—Nausea—Dactinomycin—uterine cancer	0.000517	0.00229	CcSEcCtD
Repaglinide—Gastrointestinal pain—Etoposide—uterine cancer	0.000515	0.00229	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000508	0.00225	CcSEcCtD
Repaglinide—Urticaria—Etoposide—uterine cancer	0.000501	0.00222	CcSEcCtD
Repaglinide—Jaundice—Doxorubicin—uterine cancer	0.0005	0.00222	CcSEcCtD
Repaglinide—Rhinitis—Epirubicin—uterine cancer	0.000499	0.00221	CcSEcCtD
Repaglinide—Abdominal pain—Etoposide—uterine cancer	0.000498	0.00221	CcSEcCtD
Repaglinide—Urinary tract infection—Doxorubicin—uterine cancer	0.000498	0.00221	CcSEcCtD
Repaglinide—Hepatitis—Epirubicin—uterine cancer	0.000497	0.00221	CcSEcCtD
Repaglinide—Oedema peripheral—Epirubicin—uterine cancer	0.00049	0.00217	CcSEcCtD
Repaglinide—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000485	0.00215	CcSEcCtD
Repaglinide—Sinusitis—Doxorubicin—uterine cancer	0.000481	0.00213	CcSEcCtD
Repaglinide—Visual impairment—Epirubicin—uterine cancer	0.000479	0.00213	CcSEcCtD
Repaglinide—Erythema multiforme—Epirubicin—uterine cancer	0.00047	0.00208	CcSEcCtD
Repaglinide—Eye disorder—Epirubicin—uterine cancer	0.000465	0.00206	CcSEcCtD
Repaglinide—Hypersensitivity—Etoposide—uterine cancer	0.000464	0.00206	CcSEcCtD
Repaglinide—Cardiac disorder—Epirubicin—uterine cancer	0.000462	0.00205	CcSEcCtD
Repaglinide—Rhinitis—Doxorubicin—uterine cancer	0.000461	0.00205	CcSEcCtD
Repaglinide—Hepatitis—Doxorubicin—uterine cancer	0.00046	0.00204	CcSEcCtD
Repaglinide—Oedema peripheral—Doxorubicin—uterine cancer	0.000453	0.00201	CcSEcCtD
Repaglinide—Immune system disorder—Epirubicin—uterine cancer	0.000449	0.00199	CcSEcCtD
Repaglinide—Pruritus—Etoposide—uterine cancer	0.000446	0.00198	CcSEcCtD
Repaglinide—Arrhythmia—Epirubicin—uterine cancer	0.000444	0.00197	CcSEcCtD
Repaglinide—Visual impairment—Doxorubicin—uterine cancer	0.000443	0.00197	CcSEcCtD
Repaglinide—Alopecia—Epirubicin—uterine cancer	0.000439	0.00195	CcSEcCtD
Repaglinide—Erythema multiforme—Doxorubicin—uterine cancer	0.000435	0.00193	CcSEcCtD
Repaglinide—Erythema—Epirubicin—uterine cancer	0.000433	0.00192	CcSEcCtD
Repaglinide—Malnutrition—Epirubicin—uterine cancer	0.000433	0.00192	CcSEcCtD
Repaglinide—Diarrhoea—Etoposide—uterine cancer	0.000431	0.00191	CcSEcCtD
Repaglinide—Eye disorder—Doxorubicin—uterine cancer	0.00043	0.00191	CcSEcCtD
Repaglinide—Cardiac disorder—Doxorubicin—uterine cancer	0.000427	0.00189	CcSEcCtD
Repaglinide—Back pain—Epirubicin—uterine cancer	0.000419	0.00186	CcSEcCtD
Repaglinide—Immune system disorder—Doxorubicin—uterine cancer	0.000416	0.00184	CcSEcCtD
Repaglinide—Arrhythmia—Doxorubicin—uterine cancer	0.000411	0.00182	CcSEcCtD
Repaglinide—Alopecia—Doxorubicin—uterine cancer	0.000407	0.0018	CcSEcCtD
Repaglinide—Vomiting—Etoposide—uterine cancer	0.000401	0.00178	CcSEcCtD
Repaglinide—Erythema—Doxorubicin—uterine cancer	0.000401	0.00178	CcSEcCtD
Repaglinide—Malnutrition—Doxorubicin—uterine cancer	0.000401	0.00178	CcSEcCtD
Repaglinide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	0.000398	0.00303	CbGpPWpGaD
Repaglinide—Rash—Etoposide—uterine cancer	0.000397	0.00176	CcSEcCtD
Repaglinide—Dermatitis—Etoposide—uterine cancer	0.000397	0.00176	CcSEcCtD
Repaglinide—Headache—Etoposide—uterine cancer	0.000395	0.00175	CcSEcCtD
Repaglinide—PPARG—Regulation of retinoblastoma protein—CDKN1B—uterine cancer	0.000388	0.00296	CbGpPWpGaD
Repaglinide—Leukopenia—Epirubicin—uterine cancer	0.000388	0.00172	CcSEcCtD
Repaglinide—Back pain—Doxorubicin—uterine cancer	0.000387	0.00172	CcSEcCtD
Repaglinide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	0.000386	0.00294	CbGpPWpGaD
Repaglinide—Palpitations—Epirubicin—uterine cancer	0.000383	0.0017	CcSEcCtD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000378	0.00288	CbGpPWpGaD
Repaglinide—Nausea—Etoposide—uterine cancer	0.000374	0.00166	CcSEcCtD
Repaglinide—Hypertension—Epirubicin—uterine cancer	0.000374	0.00166	CcSEcCtD
Repaglinide—Chest pain—Epirubicin—uterine cancer	0.000369	0.00163	CcSEcCtD
Repaglinide—Arthralgia—Epirubicin—uterine cancer	0.000369	0.00163	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000366	0.00162	CcSEcCtD
Repaglinide—Leukopenia—Doxorubicin—uterine cancer	0.000359	0.00159	CcSEcCtD
Repaglinide—ALB—Vitamin B12 Metabolism—MTHFR—uterine cancer	0.000356	0.00271	CbGpPWpGaD
Repaglinide—Palpitations—Doxorubicin—uterine cancer	0.000354	0.00157	CcSEcCtD
Repaglinide—Anaphylactic shock—Epirubicin—uterine cancer	0.000353	0.00157	CcSEcCtD
Repaglinide—Oedema—Epirubicin—uterine cancer	0.000353	0.00157	CcSEcCtD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000347	0.00264	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000347	0.00264	CbGpPWpGaD
Repaglinide—Thrombocytopenia—Epirubicin—uterine cancer	0.000346	0.00153	CcSEcCtD
Repaglinide—Hypertension—Doxorubicin—uterine cancer	0.000346	0.00153	CcSEcCtD
Repaglinide—Skin disorder—Epirubicin—uterine cancer	0.000343	0.00152	CcSEcCtD
Repaglinide—PPARG—Regulation of retinoblastoma protein—EP300—uterine cancer	0.000341	0.0026	CbGpPWpGaD
Repaglinide—Arthralgia—Doxorubicin—uterine cancer	0.000341	0.00151	CcSEcCtD
Repaglinide—Chest pain—Doxorubicin—uterine cancer	0.000341	0.00151	CcSEcCtD
Repaglinide—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000339	0.00258	CbGpPWpGaD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000339	0.0015	CcSEcCtD
Repaglinide—Anaphylactic shock—Doxorubicin—uterine cancer	0.000327	0.00145	CcSEcCtD
Repaglinide—Oedema—Doxorubicin—uterine cancer	0.000327	0.00145	CcSEcCtD
Repaglinide—PPARG—Signaling events mediated by HDAC Class I—EP300—uterine cancer	0.000325	0.00248	CbGpPWpGaD
Repaglinide—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000322	0.00143	CcSEcCtD
Repaglinide—Thrombocytopenia—Doxorubicin—uterine cancer	0.00032	0.00142	CcSEcCtD
Repaglinide—Skin disorder—Doxorubicin—uterine cancer	0.000318	0.00141	CcSEcCtD
Repaglinide—Paraesthesia—Epirubicin—uterine cancer	0.000317	0.00141	CcSEcCtD
Repaglinide—PPARG—Developmental Biology—HNF1B—uterine cancer	0.000317	0.00241	CbGpPWpGaD
Repaglinide—Dyspepsia—Epirubicin—uterine cancer	0.000311	0.00138	CcSEcCtD
Repaglinide—PPARG—Gene Expression—PHF1—uterine cancer	0.000308	0.00235	CbGpPWpGaD
Repaglinide—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000305	0.00135	CcSEcCtD
Repaglinide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000305	0.00232	CbGpPWpGaD
Repaglinide—Constipation—Epirubicin—uterine cancer	0.000302	0.00134	CcSEcCtD
Repaglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—EP300—uterine cancer	0.000302	0.0023	CbGpPWpGaD
Repaglinide—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000301	0.00229	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—SRD5A2—uterine cancer	0.000298	0.00227	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—NDUFB11—uterine cancer	0.000298	0.00227	CbGpPWpGaD
Repaglinide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000298	0.00132	CcSEcCtD
Repaglinide—CYP2C8—Metapathway biotransformation—AKR1C1—uterine cancer	0.000296	0.00226	CbGpPWpGaD
Repaglinide—Paraesthesia—Doxorubicin—uterine cancer	0.000294	0.0013	CcSEcCtD
Repaglinide—ALB—Folate Metabolism—MTHFR—uterine cancer	0.000289	0.00221	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—SRD5A2—uterine cancer	0.000289	0.0022	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—NDUFB11—uterine cancer	0.000289	0.0022	CbGpPWpGaD
Repaglinide—Gastrointestinal pain—Epirubicin—uterine cancer	0.000289	0.00128	CcSEcCtD
Repaglinide—Dyspepsia—Doxorubicin—uterine cancer	0.000288	0.00128	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000282	0.00125	CcSEcCtD
Repaglinide—Urticaria—Epirubicin—uterine cancer	0.000281	0.00124	CcSEcCtD
Repaglinide—Constipation—Doxorubicin—uterine cancer	0.00028	0.00124	CcSEcCtD
Repaglinide—Abdominal pain—Epirubicin—uterine cancer	0.000279	0.00124	CcSEcCtD
Repaglinide—ALB—Vitamin B12 Metabolism—CCL2—uterine cancer	0.000278	0.00212	CbGpPWpGaD
Repaglinide—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000277	0.00212	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000273	0.00208	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000273	0.00208	CbGpPWpGaD
Repaglinide—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000267	0.00119	CcSEcCtD
Repaglinide—PPARG—Gene Expression—CHD4—uterine cancer	0.000262	0.002	CbGpPWpGaD
Repaglinide—Hypersensitivity—Epirubicin—uterine cancer	0.00026	0.00115	CcSEcCtD
Repaglinide—CYP2C8—Metapathway biotransformation—GPX3—uterine cancer	0.00026	0.00198	CbGpPWpGaD
Repaglinide—Urticaria—Doxorubicin—uterine cancer	0.00026	0.00115	CcSEcCtD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.00026	0.00198	CbGpPWpGaD
Repaglinide—Abdominal pain—Doxorubicin—uterine cancer	0.000258	0.00115	CcSEcCtD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000255	0.00194	CbGpPWpGaD
Repaglinide—Pruritus—Epirubicin—uterine cancer	0.00025	0.00111	CcSEcCtD
Repaglinide—PPARG—Wnt Signaling Pathway Netpath—AKT1—uterine cancer	0.000249	0.0019	CbGpPWpGaD
Repaglinide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000247	0.00188	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—CYP11A1—uterine cancer	0.000245	0.00186	CbGpPWpGaD
Repaglinide—PPARG—SREBP signalling—PIK3CA—uterine cancer	0.000244	0.00186	CbGpPWpGaD
Repaglinide—Diarrhoea—Epirubicin—uterine cancer	0.000242	0.00107	CcSEcCtD
Repaglinide—CYP2C8—Metapathway biotransformation—CYP11A1—uterine cancer	0.000241	0.00184	CbGpPWpGaD
Repaglinide—Hypersensitivity—Doxorubicin—uterine cancer	0.000241	0.00107	CcSEcCtD
Repaglinide—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000233	0.00177	CbGpPWpGaD
Repaglinide—Pruritus—Doxorubicin—uterine cancer	0.000231	0.00103	CcSEcCtD
Repaglinide—ALB—Selenium Micronutrient Network—MTHFR—uterine cancer	0.00023	0.00175	CbGpPWpGaD
Repaglinide—CYP2C8—Metapathway biotransformation—AKR1C3—uterine cancer	0.000228	0.00174	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—PGR—uterine cancer	0.000227	0.00173	CbGpPWpGaD
Repaglinide—PPARG—PPARA activates gene expression—EP300—uterine cancer	0.000227	0.00173	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—CCL2—uterine cancer	0.000226	0.00173	CbGpPWpGaD
Repaglinide—Vomiting—Epirubicin—uterine cancer	0.000225	0.000996	CcSEcCtD
Repaglinide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000224	0.00171	CbGpPWpGaD
Repaglinide—Diarrhoea—Doxorubicin—uterine cancer	0.000224	0.000992	CcSEcCtD
Repaglinide—Rash—Epirubicin—uterine cancer	0.000223	0.000988	CcSEcCtD
Repaglinide—Dermatitis—Epirubicin—uterine cancer	0.000223	0.000987	CcSEcCtD
Repaglinide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	0.000222	0.00169	CbGpPWpGaD
Repaglinide—Headache—Epirubicin—uterine cancer	0.000221	0.000981	CcSEcCtD
Repaglinide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000221	0.00169	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—SUZ12—uterine cancer	0.00022	0.00168	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000217	0.00166	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	0.000216	0.00165	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000216	0.00165	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—AKR1B1—uterine cancer	0.000216	0.00164	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—STAR—uterine cancer	0.000216	0.00164	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—NDUFB11—uterine cancer	0.000214	0.00163	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—SRD5A2—uterine cancer	0.000214	0.00163	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—CTNNB1—uterine cancer	0.000213	0.00163	CbGpPWpGaD
Repaglinide—Nausea—Epirubicin—uterine cancer	0.00021	0.000931	CcSEcCtD
Repaglinide—KCNJ11—Metabolism—STAR—uterine cancer	0.000209	0.00159	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—AKR1B1—uterine cancer	0.000209	0.00159	CbGpPWpGaD
Repaglinide—Vomiting—Doxorubicin—uterine cancer	0.000208	0.000922	CcSEcCtD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000208	0.00158	CbGpPWpGaD
Repaglinide—Rash—Doxorubicin—uterine cancer	0.000206	0.000914	CcSEcCtD
Repaglinide—Dermatitis—Doxorubicin—uterine cancer	0.000206	0.000913	CcSEcCtD
Repaglinide—Headache—Doxorubicin—uterine cancer	0.000205	0.000908	CcSEcCtD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.0002	0.00153	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—ESR2—uterine cancer	0.0002	0.00153	CbGpPWpGaD
Repaglinide—PPARG—SREBP signalling—AKT1—uterine cancer	0.000199	0.00152	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000196	0.00149	CbGpPWpGaD
Repaglinide—Nausea—Doxorubicin—uterine cancer	0.000194	0.000861	CcSEcCtD
Repaglinide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000182	0.00139	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	0.00018	0.00137	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—CCL2—uterine cancer	0.00018	0.00137	CbGpPWpGaD
Repaglinide—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	0.000177	0.00135	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—POLD1—uterine cancer	0.000169	0.00129	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—NDUFB11—uterine cancer	0.000168	0.00128	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—SRD5A2—uterine cancer	0.000168	0.00128	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—POLD1—uterine cancer	0.000164	0.00125	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000163	0.00125	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000163	0.00124	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	0.000159	0.00121	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—AKR1C1—uterine cancer	0.000158	0.00121	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000157	0.0012	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000157	0.0012	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000156	0.00119	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000156	0.00119	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—STAR—uterine cancer	0.000154	0.00118	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AKR1B1—uterine cancer	0.000154	0.00118	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000154	0.00118	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—AKR1C1—uterine cancer	0.000153	0.00117	CbGpPWpGaD
Repaglinide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	0.000153	0.00117	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000153	0.00116	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—SMAD3—uterine cancer	0.000149	0.00113	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000148	0.00113	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—PTEN—uterine cancer	0.000147	0.00112	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—RRM2—uterine cancer	0.000141	0.00108	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—EP300—uterine cancer	0.00014	0.00107	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—SMAD3—uterine cancer	0.00014	0.00107	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	0.000139	0.00106	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—DCN—uterine cancer	0.000137	0.00104	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—RRM2—uterine cancer	0.000137	0.00104	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—DCN—uterine cancer	0.000133	0.00101	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	0.000131	0.001	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	0.000129	0.000987	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CYP11A1—uterine cancer	0.000129	0.000983	CbGpPWpGaD
Repaglinide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	0.000128	0.000978	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CYP11A1—uterine cancer	0.000125	0.000954	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—VEGFA—uterine cancer	0.000125	0.00095	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	0.000122	0.000932	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—AKR1C3—uterine cancer	0.000122	0.000929	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—STAR—uterine cancer	0.000122	0.000928	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AKR1B1—uterine cancer	0.000122	0.000928	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—ESR1—uterine cancer	0.000121	0.000925	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—POLD1—uterine cancer	0.000121	0.000924	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.00012	0.000917	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	0.000119	0.000905	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—AKR1C3—uterine cancer	0.000118	0.000901	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000115	0.000878	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MET—uterine cancer	0.000115	0.000874	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000115	0.000873	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AKR1C1—uterine cancer	0.000113	0.000865	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—TP53—uterine cancer	0.00011	0.000837	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—PGR—uterine cancer	0.000109	0.000834	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—EZH2—uterine cancer	0.000104	0.000792	CbGpPWpGaD
Repaglinide—ABCC8—Neuronal System—HRAS—uterine cancer	0.000103	0.000784	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—RRM2—uterine cancer	0.000101	0.000771	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—TP53—uterine cancer	0.0001	0.000764	CbGpPWpGaD
Repaglinide—KCNJ11—Neuronal System—HRAS—uterine cancer	9.97e-05	0.00076	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—DCN—uterine cancer	9.81e-05	0.000748	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NDUFB11—uterine cancer	9.67e-05	0.000737	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SRD5A2—uterine cancer	9.67e-05	0.000737	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	9.66e-05	0.000736	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IRF1—uterine cancer	9.63e-05	0.000735	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—ESR2—uterine cancer	9.63e-05	0.000734	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SRD5A2—uterine cancer	9.61e-05	0.000733	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NDUFB11—uterine cancer	9.61e-05	0.000733	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—POLD1—uterine cancer	9.55e-05	0.000728	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	9.52e-05	0.000726	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—STK11—uterine cancer	9.49e-05	0.000724	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CYP19A1—uterine cancer	9.49e-05	0.000724	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	9.39e-05	0.000716	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	9.34e-05	0.000712	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CYP11A1—uterine cancer	9.24e-05	0.000705	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—STK11—uterine cancer	9.2e-05	0.000702	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CYP19A1—uterine cancer	9.2e-05	0.000702	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AKR1C1—uterine cancer	8.93e-05	0.000681	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	8.87e-05	0.000676	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	8.82e-05	0.000672	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AKR1C3—uterine cancer	8.73e-05	0.000666	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—ERBB2—uterine cancer	8.38e-05	0.000639	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—RRM2—uterine cancer	7.96e-05	0.000607	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—CDKN2B—uterine cancer	7.84e-05	0.000598	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—DCN—uterine cancer	7.73e-05	0.000589	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—CTNNB1—uterine cancer	7.33e-05	0.000559	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP11A1—uterine cancer	7.28e-05	0.000555	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—SMAD3—uterine cancer	7.16e-05	0.000546	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—MTHFR—uterine cancer	7.13e-05	0.000544	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—STAR—uterine cancer	6.99e-05	0.000533	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AKR1B1—uterine cancer	6.99e-05	0.000533	CbGpPWpGaD
Repaglinide—ALB—Metabolism—STAR—uterine cancer	6.95e-05	0.00053	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AKR1B1—uterine cancer	6.95e-05	0.00053	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—MTHFR—uterine cancer	6.91e-05	0.000527	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.91e-05	0.000527	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AKR1C3—uterine cancer	6.87e-05	0.000524	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.87e-05	0.000524	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—EP300—uterine cancer	6.82e-05	0.00052	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CYP19A1—uterine cancer	6.8e-05	0.000519	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—STK11—uterine cancer	6.8e-05	0.000519	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—VEGFA—uterine cancer	6.46e-05	0.000492	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.38e-05	0.000487	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—NRAS—uterine cancer	6.38e-05	0.000486	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.09e-05	0.000464	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—ESR1—uterine cancer	5.84e-05	0.000445	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	5.53e-05	0.000421	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—KRAS—uterine cancer	5.49e-05	0.000418	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—POLD1—uterine cancer	5.48e-05	0.000418	CbGpPWpGaD
Repaglinide—ALB—Metabolism—POLD1—uterine cancer	5.45e-05	0.000416	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—STK11—uterine cancer	5.35e-05	0.000408	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP19A1—uterine cancer	5.35e-05	0.000408	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NDUFB11—uterine cancer	5.19e-05	0.000396	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SRD5A2—uterine cancer	5.19e-05	0.000396	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AKR1C1—uterine cancer	5.13e-05	0.000391	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—MTHFR—uterine cancer	5.11e-05	0.00039	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AKR1C1—uterine cancer	5.1e-05	0.000389	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.03e-05	0.000383	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.79e-05	0.000366	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—HRAS—uterine cancer	4.66e-05	0.000356	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—RRM2—uterine cancer	4.57e-05	0.000349	CbGpPWpGaD
Repaglinide—ALB—Metabolism—RRM2—uterine cancer	4.55e-05	0.000347	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.5e-05	0.000343	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—DCN—uterine cancer	4.44e-05	0.000338	CbGpPWpGaD
Repaglinide—ALB—Metabolism—DCN—uterine cancer	4.41e-05	0.000337	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	4.32e-05	0.000329	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP11A1—uterine cancer	4.18e-05	0.000319	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP11A1—uterine cancer	4.16e-05	0.000317	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—AKT1—uterine cancer	4.12e-05	0.000314	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—MTHFR—uterine cancer	4.02e-05	0.000307	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTEN—uterine cancer	3.97e-05	0.000302	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AKR1C3—uterine cancer	3.95e-05	0.000301	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AKR1C3—uterine cancer	3.93e-05	0.000299	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTEN—uterine cancer	3.85e-05	0.000293	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—EP300—uterine cancer	3.78e-05	0.000288	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—STAR—uterine cancer	3.75e-05	0.000286	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AKR1B1—uterine cancer	3.75e-05	0.000286	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—EP300—uterine cancer	3.67e-05	0.00028	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.55e-05	0.00027	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	3.53e-05	0.000269	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP19A1—uterine cancer	3.08e-05	0.000235	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—STK11—uterine cancer	3.08e-05	0.000235	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP19A1—uterine cancer	3.06e-05	0.000233	CbGpPWpGaD
Repaglinide—ALB—Metabolism—STK11—uterine cancer	3.06e-05	0.000233	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—EP300—uterine cancer	3.01e-05	0.000229	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—POLD1—uterine cancer	2.94e-05	0.000224	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.89e-05	0.00022	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.87e-05	0.000219	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—VEGFA—uterine cancer	2.85e-05	0.000217	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTEN—uterine cancer	2.84e-05	0.000217	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NRAS—uterine cancer	2.81e-05	0.000215	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CA—uterine cancer	2.8e-05	0.000213	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.75e-05	0.00021	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AKR1C1—uterine cancer	2.75e-05	0.00021	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.74e-05	0.000209	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CA—uterine cancer	2.71e-05	0.000207	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—EP300—uterine cancer	2.71e-05	0.000207	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—RRM2—uterine cancer	2.45e-05	0.000187	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—KRAS—uterine cancer	2.42e-05	0.000185	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—DCN—uterine cancer	2.38e-05	0.000182	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—MTHFR—uterine cancer	2.31e-05	0.000176	CbGpPWpGaD
Repaglinide—ALB—Metabolism—MTHFR—uterine cancer	2.3e-05	0.000175	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—AKT1—uterine cancer	2.29e-05	0.000174	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.24e-05	0.000171	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTEN—uterine cancer	2.24e-05	0.000171	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CA—uterine cancer	2.23e-05	0.00017	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—AKT1—uterine cancer	2.22e-05	0.000169	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TP53—uterine cancer	2.15e-05	0.000164	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—EP300—uterine cancer	2.13e-05	0.000163	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AKR1C3—uterine cancer	2.12e-05	0.000162	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—AKT1—uterine cancer	2.11e-05	0.000161	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—HRAS—uterine cancer	2.06e-05	0.000157	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.04e-05	0.000155	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.03e-05	0.000154	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CA—uterine cancer	2.01e-05	0.000153	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—AKT1—uterine cancer	1.82e-05	0.000139	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.65e-05	0.000126	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—STK11—uterine cancer	1.65e-05	0.000126	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AKT1—uterine cancer	1.64e-05	0.000125	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CA—uterine cancer	1.58e-05	0.00012	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AKT1—uterine cancer	1.29e-05	9.84e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTEN—uterine cancer	1.29e-05	9.81e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTEN—uterine cancer	1.28e-05	9.75e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—MTHFR—uterine cancer	1.24e-05	9.46e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—EP300—uterine cancer	1.23e-05	9.35e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—EP300—uterine cancer	1.22e-05	9.3e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CA—uterine cancer	9.07e-06	6.92e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CA—uterine cancer	9.02e-06	6.88e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AKT1—uterine cancer	7.41e-06	5.65e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AKT1—uterine cancer	7.37e-06	5.62e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTEN—uterine cancer	6.9e-06	5.26e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—EP300—uterine cancer	6.58e-06	5.02e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CA—uterine cancer	4.87e-06	3.71e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AKT1—uterine cancer	3.98e-06	3.03e-05	CbGpPWpGaD
